Powerlifting Athlete Suspended for Presence of Ephedrine
published on 12 October 2018
12th October 2018
The Canadian Centre for Ethics in Sport (CCES) announced today that David Troeung, a powerlifting athlete, received a four-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on July 21, 2018, revealed the presence of ephedrine, a prohibited stimulant.
The presence of ephedrine, classified as a “specified substance” on the Prohibited List, is considered an adverse analytical finding when the urinary concentration exceeds 10 mcg/mL. Under the rules of the Canadian Anti-Doping Program (CADP), the sanction for an anti-doping rule violation involving a specified substance may be increased if the CCES determines that the athlete acted with intent. Based on the CCES’s assessment of the circumstances, the CCES proposed a four-year period of ineligibility.
In response to the CCES’s notification of the adverse analytical finding, Mr. Troeung waived his right to a hearing and accepted the proposed sanction, which terminates on August 18, 2022. The athlete, who resides in Toronto, Ontario, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates, during the sanction period.
In compliance with rule 7.10 of the CADP, a copy of the CCES’s file outcome summary can be found at www.cces.ca/sanctionreg.
- Tags: Anti-Doping | Athletics | Canadian Anti-Doping Program (CADP) | Canadian Centre for Ethics in Sport (CCES) | Powerlifting | Prohibited Stimulant